Boston Implements GLP-1 Coverage Restrictions for City Employees
Boston's plan to restrict GLP-1 drug coverage will save $11 million while managing rising healthcare costs for city employees. Learn more about this critical initiative.
Boston's plan to restrict GLP-1 drug coverage will save $11 million while managing rising healthcare costs for city employees. Learn more about this critical initiative.
P3 Health Partners Inc. partners with a nonprofit health insurer in Nebraska to enhance Medicare Advantage support for providers and transition to global risk management by 2028.
Explore how funding cuts threaten HIV/AIDS programs and the implications for public health and insurance markets in the U.S. Learn why this issue matters.
Explore the urgent healthcare challenges in California's Rural North, highlighting costs, access, and the need for effective policy measures.
Explore how states leverage CHIP HSIs to enhance children’s health amidst financial constraints, maximizing federal funds while ensuring program sustainability.
Explore the vital transformations in federal health laws affecting Medicare, Medicaid, and drug pricing as we prepare for 2026. Key insights for stakeholders.
Starting July 1, 2025, FQHCs face new Medicare billing rules for vaccines, enhancing cash flow while ensuring compliance. Consult experts for the best practices.
Discover how Medicaid and CHIP play a crucial role in covering children's health insurance in U.S. school districts amid evolving regulations.
Discover health insurance Q4 earnings trends, regulatory impacts, and the role of AI in shaping the industry. Key insights for providers and investors.
Explore how the end of ACA subsidies impacts older Americans' healthcare, forcing many to delay essential medical services until Medicare eligibility.